{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:11:31Z","timestamp":1792631491882,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3605100"],"award-info":[{"award-number":["2023YFC3605100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004024","name":"Jinan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113924","type":"journal-article","created":{"date-parts":[[2024,12,27]],"date-time":"2024-12-27T03:47:18Z","timestamp":1735271238000},"page":"113924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Dexmedetomidine therapy promotes cardiac dysfunction and increases mortality in sepsis: A translational study"],"prefix":"10.1016","volume":"146","author":[{"given":"Liaoyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomeng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxiu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuixing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huadong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.intimp.2024.113924_b0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.intimp.2024.113924_b0010","article-title":"The prognostic impact of SIGLEC5-induced impairment of CD8+ T cell activation in sepsis","volume":"97","author":"Roberto","year":"2023","journal-title":"EBioMedicine"},{"issue":"10219","key":"10.1016\/j.intimp.2024.113924_b0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.intimp.2024.113924_b0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","article-title":"Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis","volume":"24","author":"Bauer","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.intimp.2024.113924_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104318","article-title":"Current sepsis therapeutics","volume":"86","author":"Vincent","year":"2022","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.intimp.2024.113924_b0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.34290","article-title":"Epidemiology and costs of postsepsis morbidity, nursing care dependency, and mortality in Germany, 2013 to 2017","volume":"4","author":"Fleischmann-Struzek","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.intimp.2024.113924_b0035","first-page":"30","article-title":"Pathophysiology of sepsis-induced myocardial dysfunction","volume":"3","author":"Lv","year":"2016","journal-title":"Mil. Med. Res."},{"issue":"4","key":"10.1016\/j.intimp.2024.113924_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100767","article-title":"Septic cardiomyopathy: from basics to management choices","volume":"46","author":"Ravikumar","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113924_b0045","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.chest.2020.09.274","article-title":"Right ventricular dysfunction in early sepsis and septic shock","volume":"159","author":"Lanspa","year":"2021","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.intimp.2024.113924_b0050","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00134-021-06479-y","article-title":"Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis","volume":"47","author":"Kosyakovsky","year":"2021","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.intimp.2024.113924_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105257","article-title":"Blood pressure response index and clinical outcomes in patients with septic shock: a multicenter cohort study","volume":"106","author":"Chen","year":"2024","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.intimp.2024.113924_b0060","article-title":"Activation of myocardial phosphoinositide-3-kinase p110\u03b1 ameliorates cardiac dysfunction and improves survival in polymicrobial sepsis","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.intimp.2024.113924_b0065","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","article-title":"Pathophysiology of sepsis-induced cardiomyopathy","volume":"18","author":"Hollenberg","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113924_b0070","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11897-014-0247-z","article-title":"Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?","volume":"12","author":"Drosatos","year":"2015","journal-title":"Curr. Heart Fail. Rep."},{"issue":"10","key":"10.1016\/j.intimp.2024.113924_b0075","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40265-015-0419-5","article-title":"Dexmedetomidine: a review of its use for sedation in the intensive care setting","volume":"75","author":"Keating","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2024.113924_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.05.030","article-title":"Dexmedetomidine effects in different experimental sepsis in vivo models","volume":"856","author":"Dardalas","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113924_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109231","article-title":"Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of \u03b17nAChR and PI3K\/Akt- mediated autophagy","volume":"120","author":"Yu","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.intimp.2024.113924_b0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3892\/mmr.2020.11114","article-title":"Dexmedetomidine alleviated sepsis\u2011induced myocardial ferroptosis and septic heart injury","volume":"22","author":"Wang","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.113924_b0095","article-title":"\u03b12A-adrenergic blockade attenuates septic cardiomyopathy by increasing cardiac norepinephrine concentration and inhibiting cardiac endothelial activation","volume":"8","author":"Yu","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2024.113924_b0100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00540-008-0611-9","article-title":"Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats","volume":"22","author":"Taniguchi","year":"2008","journal-title":"J. Anesth."},{"issue":"2","key":"10.1016\/j.intimp.2024.113924_b0105","doi-asserted-by":"crossref","DOI":"10.1186\/cc8916","article-title":"Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial","volume":"14","author":"Pandharipande","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.intimp.2024.113924_b0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcrc.2015.11.013","article-title":"Survival benefits of dexmedetomidine used for sedating septic patients in intensive care setting: a systematic review","volume":"32","author":"Zamani","year":"2016","journal-title":"J. Crit. Care"},{"issue":"13","key":"10.1016\/j.intimp.2024.113924_b0115","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/jama.2017.2088","article-title":"Dexmedetomidine for sepsis in intensive care unit randomized evaluation (DESIRE) trial investigators. Effect of dexmedetomidine on mortality and ventilator-free days in patients requiring mechanical ventilation with sepsis: a randomized clinical trial","volume":"317","author":"Kawazoe","year":"2017","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.intimp.2024.113924_b0120","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1056\/NEJMoa2024922","article-title":"Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis","volume":"384","author":"Hughes","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113924_b0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nprot.2008.214","article-title":"Immunodesign of experimental sepsis by cecal ligation and puncture","volume":"4","author":"Rittirsch","year":"2009","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.intimp.2024.113924_b0130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s42003-022-03007-6","article-title":"Intrinsic cardiac adrenergic cells contribute to LPS-induced myocardial dysfunction","volume":"5","author":"Yang","year":"2022","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113924_b0135","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1096\/fj.00-0433fje","article-title":"Cardiac contractile impairment associated with increased phosphorylation of troponin I in endotoxemic rats","volume":"15","author":"Tavernier","year":"2001","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.intimp.2024.113924_b0140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13613-022-01052-2","article-title":"Use of dexmedetomidine in patients with sepsis: a systematic review and meta-analysis of randomized-controlled trials","volume":"12","author":"Zhang","year":"2022","journal-title":"Ann. Intensive Care"},{"issue":"5","key":"10.1016\/j.intimp.2024.113924_b0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3892\/etm.2020.9186","article-title":"Altered function of the left ventricle and clinical significance of heart-type fatty acid-binding protein in cardiac dysfunction among patients with sepsis","volume":"20","author":"Weng","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2024.113924_b0150","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8897738","article-title":"Diagnostic value of high-sensitivity troponin T for subclinical left ventricular systolic dysfunction in patients with sepsis","volume":"2021","author":"Hai","year":"2021","journal-title":"Cardiol. Res. Pract."},{"issue":"4","key":"10.1016\/j.intimp.2024.113924_b0155","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/SHK.0000000000001718","article-title":"The long-term effect of dobutamine on intrinsic myocardial function and myocardial injury in septic rats with myocardial dysfunction","volume":"56","author":"Tang","year":"2021","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.intimp.2024.113924_b0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/SHK.0000000000000065","article-title":"Characterization of cardiac dysfunction in sepsis: an ongoing challenge","volume":"41","author":"Zaky","year":"2014","journal-title":"Shock"},{"issue":"2","key":"10.1016\/j.intimp.2024.113924_b0165","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0735-1097(97)88335-0","article-title":"Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function","volume":"30","author":"Sohn","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113924_b0170","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.4314\/ahs.v20i4.27","article-title":"Relationship of left ventricular and atrial dimensions with moderate to severe left ventricular diastolic dysfunction (grade II and above)","volume":"20","author":"Hamza","year":"2020","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.intimp.2024.113924_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105898","article-title":"Dexmedetomidine-mediated protection against septic liver injury depends on TLR4\/MyD88\/NF-kappaB signaling downregulation partly via cholinergic anti-inflammatory mechanisms","volume":"76","author":"Zi","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113924_b0180","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s40262-017-0507-7","article-title":"Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine","volume":"56","author":"Weerink","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.intimp.2024.113924_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109724","article-title":"Posttreatment with dexmedetomidine aggravates LPS-induced myocardial dysfunction partly via activating cardiac endothelial alpha(2A)-AR in mice","volume":"116","author":"Tang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113924_b0190","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.4049\/jimmunol.145.5.1430","article-title":"Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor","volume":"145","author":"Spengler","year":"1990","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113924_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005504","article-title":"Pivotal role of the alpha(2A)-adrenoceptor in producing inflammation and organ injury in a rat model of sepsis","volume":"4","author":"Miksa","year":"2009","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.intimp.2024.113924_b0200","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1002\/jcp.29586","article-title":"\u03b12A-AR antagonism by BRL-44408 maleate attenuates acute lung injury in rats with downregulation of ERK1\/2, p38MAPK, and p65 pathway","volume":"235","author":"Cong","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113924_b0205","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s10753-014-9906-1","article-title":"Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway","volume":"37","author":"Xiang","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2024.113924_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108920","article-title":"Dexmedetomidine attenuates lipopolysaccharide-induced inflammation through macrophageal IL-10 expression following \u03b17 nAchR activation","volume":"109","author":"Han","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.intimp.2024.113924_b0215","first-page":"5040","article-title":"Dexmedetomidine alleviates LPS-induced septic cardiomyopathy via the cholinergic anti-inflammatory pathway in mice","volume":"9","author":"Kong","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.intimp.2024.113924_b0220","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.biopha.2018.06.059","article-title":"Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an \u03b17nAChR-dependent pathway","volume":"106","author":"Kang","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"23","key":"10.1016\/j.intimp.2024.113924_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312749","article-title":"Dexmedetomidine promotes lipopolysaccharide-induced differentiation of cardiac fibroblasts and collagen I\/III synthesis through \u03b12A adrenoreceptor-mediated activation of the PKC-p38-Smad2\/3 signaling pathway in mice","volume":"22","author":"Liao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.113924_b0230","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2478\/jtim-2023-0088","article-title":"A generalized deep learning model for heart failure diagnosis using dynamic and static ultrasound","volume":"11","author":"Liu","year":"2023","journal-title":"J. Transl. Int. Med."},{"issue":"6","key":"10.1016\/j.intimp.2024.113924_b0235","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/1060028019895502","article-title":"Hemodynamic effects of propofol and dexmedetomidine in septic patients without shock","volume":"54","author":"Benken","year":"2020","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.intimp.2024.113924_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110327","article-title":"Differential effects of dexmedetomidine on Gram-positive and Gram-negative bacterial killing and phagocytosis","volume":"120","author":"Maisat","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113924_b0245","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2478\/jtim-2023-0125","article-title":"Temporal trend of acute myocardial infarction-related mortality and associated racial\/ethnic disparities during the omicron outbreak","volume":"11","author":"Yeo","year":"2023","journal-title":"J. Transl. Int. Med."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T16:55:05Z","timestamp":1736614505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924024469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":49,"alternative-id":["S1567576924024469"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113924","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dexmedetomidine therapy promotes cardiac dysfunction and increases mortality in sepsis: A translational study","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113924"}}